This site is called Alpha1Life. It is about life and living healthier, longer, and vibrantly with excitement! Mark Egly is the founder of this site. Mark is self-diagnosed with Alpha1 Antitrypsin Deficiency.
For 46 years, Mark has been researching a medical mystery that has affected his family for over 100 years. In March 2018, Mark asked to be tested for Alpha1 Antitrypsin Deficiency after being diagnosed with emphysema and COPD with no logical explanation as to how he would have developed these conditions. Mark had his suspicions confirmed with a diagnosis after a simple blood test.
Alpha1 Antitrypsin Deficiency is a significant health issue if undiagnosed, but something that can be readily treated!
Awareness of Mark's condition led him to continue his extensive research, allowing others to have similar miracles with improved health and peace of mind that things can get better after years of little hope and desperation for many!
With Mark's patent filing in 2020, we have associated Alpha1 Antitrypsin with more conditions and diseases known by the medical community than previously thought, in our opinion.
With Mark's research, discoveries, and diagnoses, we were then able to link even more conditions that can be assisted with by the new uses of Alpha1 Antitrypsin and help patients and individuals beyond Alpha1 Antitrypsin Deficiency than ever thought before. In finding these answers, we are finding solutions for Alpha's and many other individuals who may have similar health backgrounds and health mysteries.
Our intention with this site and others is to inform the public, physicians, hospitals, medical universities, medical research programs, and medical facilities throughout the world about information with very in-depth looks into medical wisdom that is not discussed, or is rarely discussed and taught for one reason or another.
In our opinion, the medical profession has looked at Alpha-I Antitrypsin Deficiency (Genetic COPD) as a lung disease when it is not initially even lung disease. AATD is more closely associated with malfunctions occurring in just the liver. Issues within the liver are closely related to the lack of Alpha-I Antitrypsin production or the improperly unfolding of the Alpha-I Antitrypsin. Both situations in the liver cause problems and manifest disease in many individuals' lungs, but not all. Our research shows that the effects of Alpha1 Antitrypsin go way beyond the lungs and liver to many other places within the body.
Mark also feels that there are many other manifestations of this genetic flaw throughout the human body, not limited to the lungs and liver of both diagnosed and undiagnosed patients! We are bringing that information to you right here on these pages!
Who is bringing you this information? The information is being brought to you by someone who is not a doctor! The data is being brought to you by a patient with emphysema and COPD, with a confirmed diagnosis through a blood test that he has Alpha1 Antitrypsin Deficiency!
The information is being brought to you by a self-diagnosed individual with Alpha 1 Antitrypsin Deficiency that had previously suffered from many other symptoms and conditions! We believe there is much that can be done for so many unsuspecting patients, and bring an end to much of the suffering for these patients and their families!